Responsive Ads Here

Monday, February 18, 2019

Treatment for spasticity to destroy medical cannabis

Cannabinoids and Spasticity


Spasily is a motor disorder characterized by involuntary muscle spasms usually caused by disorders of the brain and the anatomy. People who develop this manifestation are burdened with involuntary muscle contractions and sometimes persistent. This contraction causes stiffness and shortening of muscles and interferes with movements and functions such as swallowing, speech and balance. The patients have a combination of paralysis, elevated activity, reflex reflex and hypertension, commonly defined as some "shrink" or "pulling" muscles.

This disorder can occur in various symptoms related to engine systems, such as metabolic crawls, such as multiple sclerosis, cerebral palsy, adrenoleukodystrophy, hypoxia, stroke and phenylketonuria. Spastics can be manifested by increased muscle tone, cramping, twitching movements, hyperreflexia tendons, abnormal posture, etc.


Interactions of cannabinoids and spasticity

The positive results come from clinical triads that show the effectiveness of cannabinoids in the treatment of spas. It is widely accepted by the medical community and specialists to advise on the use of cannabinoids for the treatment of these engine stars. Under the main triangles, the Spanish Neurology Society has established an observation study involving 50 patients with THC / CBD cervical. It was assessed that this treatment was effective in 80% of patients who were asked to catch up to 5 times a day. With this information, the Spanish neurology society concluded that "THC / CBD is a good alternative to conventional refractory spastic treatments". [1]

Another problem closed by the Neurology department in the San Carlos Clinical Hospital in Madrid: "THC + CBD oral music administration (1: 1) is approved in various EU countries, including Spain. Clinical trials have a marked reduction in spastic illnesses symptoms (stiffness, pain, sleep flow) in patients who resist other treatments.


No comments:

Post a Comment